amiodarone hydrochloride

Generic: amiodarone hydrochloride

Labeler: hf acquisition co llc, dba healthfirst
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name amiodarone hydrochloride
Generic Name amiodarone hydrochloride
Labeler hf acquisition co llc, dba healthfirst
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

amiodarone hydrochloride 50 mg/mL

Manufacturer
HF Acquisition Co LLC, DBA HealthFirst

Identifiers & Regulatory

Product NDC 51662-1205
Product ID 51662-1205_11ff1d81-1f5f-7624-e063-6294a90ad38e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA077234
Listing Expiration 2026-12-31
Marketing Start 2018-09-19

Pharmacologic Class

Classes
antiarrhythmic [epc] cytochrome p450 1a2 inhibitors [moa] cytochrome p450 2c9 inhibitors [moa] cytochrome p450 2d6 inhibitors [moa] cytochrome p450 3a inhibitors [moa] p-glycoprotein inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516621205
Hyphenated Format 51662-1205

Supplemental Identifiers

RxCUI
1663224
UNII
976728SY6Z

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name amiodarone hydrochloride (source: ndc)
Generic Name amiodarone hydrochloride (source: ndc)
Application Number ANDA077234 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 50 mg/mL
source: ndc
Packaging
  • 3 mL in 1 VIAL, SINGLE-DOSE (51662-1205-1)
  • 25 POUCH in 1 CASE (51662-1205-3) / 1 mL in 1 POUCH (51662-1205-2)
source: ndc

Packages (2)

51662-1205-1 3 mL in 1 VIAL, SINGLE-DOSE (51662-1205-1) 51662-1205-3 25 POUCH in 1 CASE (51662-1205-3) / 1 mL in 1 POUCH (51662-1205-2)

Ingredients (1)

amiodarone hydrochloride (50 mg/mL)

Linked Drug Pages (1)

AMIODARONE HYDROCHLORIDE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "11ff1d81-1f5f-7624-e063-6294a90ad38e", "openfda": {"unii": ["976728SY6Z"], "rxcui": ["1663224"], "spl_set_id": ["7639dfe4-933c-2916-e053-2a91aa0a3fe7"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "3 mL in 1 VIAL, SINGLE-DOSE (51662-1205-1)", "package_ndc": "51662-1205-1", "marketing_start_date": "20180919"}, {"sample": false, "description": "25 POUCH in 1 CASE (51662-1205-3)  / 1 mL in 1 POUCH (51662-1205-2)", "package_ndc": "51662-1205-3", "marketing_start_date": "20200615"}], "brand_name": "AMIODARONE HYDROCHLORIDE", "product_id": "51662-1205_11ff1d81-1f5f-7624-e063-6294a90ad38e", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Antiarrhythmic [EPC]", "Cytochrome P450 1A2 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "51662-1205", "generic_name": "AMIODARONE HYDROCHLORIDE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "AMIODARONE HYDROCHLORIDE", "active_ingredients": [{"name": "AMIODARONE HYDROCHLORIDE", "strength": "50 mg/mL"}], "application_number": "ANDA077234", "marketing_category": "ANDA", "marketing_start_date": "20180919", "listing_expiration_date": "20261231"}